Prediction of thyroid nodule histopathology by expert ultrasound evaluation by Håskjold, Olav Inge et al.
10:7 776–781O I Håskjold et al. Ultrasound prediction of 
thyroid histology
RESEARCH
Prediction of thyroid nodule histopathology by 
expert ultrasound evaluation
Olav Inge Håskjold1, Henrik Stenestø Foshaug2, Therese Benedikte Iversen3, Helga Charlotte Kjøren3 and 
Vegard Heimly Brun 1,2
1Department of Breast and Endocrine Surgery, University Hospital of North Norway, Tromsø, Norway
2UiT – The Arctic University of Norway, Institute of Clinical Medicine, Tromsø, Norway
3Department of Radiology, University Hospital of North Norway, Harstad, Norway
Correspondence should be addressed to V H Brun: vegard.h.brun@uit.no
Abstract
Objective: The basis of thyroid nodule diagnostics is ultrasound-guided fine needle 
biopsy with cytological evaluation (FNC) if ultrasound appearance is not clearly benign. 
The aim of this study was to investigate the predictive potential of dedicated, expert 
high-resolution ultrasound, to see if histopathological entities of thyroid nodules can be 
diagnosed without invasive FNC biopsies.
Design: Prospective case-cohort study.
Methods: 187 patients with 221 thyroid nodules were examined with ultrasound and 
prospectively assigned to the expected histopathological diagnosis: colloid nodule, 
adenomatoid colloid nodule, follicular adenoma, follicular carcinoma, follicular variant of 
papillary thyroid carcinoma, papillary thyroid carcinoma, or other thyroid cancer. In 101 
of these, we later obtained histopathological reports for comparison.
Results: Overall accuracy for classification into discrete histopathological categories by 
expert ultrasound was 71.3% and Cohen’s Kappa was 0.62. The sensitivity and specificity 
for detecting malignancy were 97.3% and 78.1%. The diagnostic accuracy for malignancy 
was 85.1%. ACR-TIRADS scores for the same nodules had a sensitivity of 97.3%, specificity 
of 26.6%, and accuracy of 52.5%.
Conclusion: Dedicated expert high-resolution ultrasound without FNC can reliably 
distinguish benign vs malignant nodules, but also differentiate between several 
histopathological entities in thyroid nodules. There is potential for a reduction in the 
number of invasive FNC biopsies and diagnostic operations.
Introduction
Surgery of the thyroid gland can be indicated because 
of compression symptoms, thyrotoxicosis, or cancer. 
However, typically 35–40% of surgeries in Europe are 
made when examination including fine-needle cytology 
(FNC) biopsy fail to exclude malignancy, according to the 
European database EUROCRINE (www.eurocrine.eu). In 
most of these cases, the final histology is benign, indicating 
overdiagnosis and overtreatment of thyroid nodules (1, 2).
In order to reduce overtreatment of thyroid nodules, 
improvements in the diagnostic workup are continuously 
being made. Ultrasound (US) is the primary radiological 
modality for the evaluation of thyroid nodules and has 
undergone significant technical development. While US 
was considered unsuitable to distinguish between benign 
and malignant thyroid nodules 1 or 2 decades ago (3, 4), 
now it has a central place in several risk stratification systems 
(RSS) for detection of thyroid malignancy (5). Among 
the RSS, there are several versions of Thyroid Imaging 
Reporting and Data Systems (TIRADS) published in the 
last 5 years (6, 7, 8). The RSS are helpful to standardize and 
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improve the radiological examination, but consensus on 
a common system is hindered by low inter-rater reliability 
and variation in the malignancy risk associated with each 
category (9, 10, 11, 12).
FNC by ultrasound guidance is the required standard 
for thyroid nodule cytology, in contrast to FNC guided 
by palpation. Although US is accepted as necessary for 
the selection of suspicious nodules, US characteristics 
of thyroid nodules are often considered unspecific. 
Consequently, the decision about surgery is predominantly 
based on cytological evaluation, and the US evaluation in 
itself is not emphasized in the diagnostic workup. This 
is true despite the fact that cytology has a diagnostic 
accuracy of only 70% (13). Some studies show, however, 
that in cases of uncertain cytology, US evaluation can help 
to decide when diagnostic surgery is warranted (14, 15). In 
addition, emerging results from artificial intelligence (AI) 
algorithms show that the US images themselves contain 
enough information to predict malignancy with diagnostic 
accuracy comparable to cytological evaluation (16, 17).
We wanted to explore the diagnostic potential of 
recognition-based thyroid US, without cytology, when 
performed by a dedicated radiologist. The aim was to 
evaluate if the US evaluation alone can predict subtypes of 
benign and malignant histopathological entities.
Materials and methods
Patient inclusion and prospective 
ultrasound evaluation
187 patients referred to our clinic were consecutively 
enrolled in this study between February 2018 and April 
2019. The reasons for referral were either symptomatic 
thyroid nodules or incidentally discovered thyroid 
nodules. The same expert thyroid ultrasound operator with 
more than a decade of thyroid-specific experience from 
University clinics evaluated 221 thyroid nodules. None 
of the patients had previous biopsies or cytology reports, 
but some had US examinations at referring clinics. Thirty-
six of the nodules were also assessed and scored by a less 
experienced ultrasound operator. This subset of nodules 
was pseudorandomly selected by the days both operators 
were present in the clinic. The two operators were never 
present in the examining room simultaneously, and the 
scorings were performed prior to any communication 
between the two to ensure independent assessments. All 
exams were performed using a Philips Epiq 5G ultrasound 
machine (Phillips Ultrasound Inc, Bothell, WA, USA), 
with a L12-5 linear array transducer. We used a pre-
determined custom scoring template with categories 
corresponding to the most common histological diagnoses: 
colloid nodule, adenomatoid colloid nodule, follicular 
adenoma, follicular carcinoma, follicular variant of 
papillary thyroid carcinoma, papillary thyroid carcinoma, 
or other thyroid cancer. The operator also indicated the 
confidence of the assignment to any category on a scale 
from 1 to 5 (1 = very uncertain, 2 = uncertain, 3 = neutral, 
4 = certain, 5 = very certain).
The position of each evaluated nodule was indicated 
on a drawing of the thyroid gland, and its size was 
recorded, to ensure that later comparison with histology 
would be of the very same nodule. In cases of uncertainty, 
multiple categories were sometimes marked, but the 
category with the highest score was used for all analyses. 
After scoring, further diagnostic workup and treatment 
followed a clinical routine, including cytological biopsies if 
indicated. Evaluation for surgery was carried out according 
to national and international guidelines by surgeons and 
the multidisciplinary team who had no knowledge about 
the patient’s participation in this study.
Histological evaluation
When patient inclusion was complete, we searched the 
hospital records of the patients and found that 98 of the 
assessed nodules were removed by surgery and 3 had 
undergone large needle biopsy (all anaplastic thyroid 
carcinomas). This allowed a comparison between initial 
ultrasound assessment and final histology for 101 nodules 
in total. Histological reports were manually categorized to 
harmonize with the pre-determined histological classes. 
For example, benign Hürthle cell adenomas were assigned 
to the follicular adenoma category. For most reports, no 
harmonization was necessary. In cases of multiple entities 
in the histological specimen, for example, the incidental 
finding of a papillary microcarcinoma (mPTC) embedded 
in colloid nodules, care was made to match the nodule 
evaluated by ultrasound to the histological description 
of the same area. Thus, histological mPTCs < 5 mm were 
disregarded in the analysis if found incidentally after 
surgery for larger nodules of another entity.
ACR-TIRADS classification
Ultrasound images were stored offline as video files 
containing transversal cine loops with approximately 
250–500 frames per cine loop from each thyroid lobe. 
The scan was made from the submandibular gland to 
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the supraclavicular fossa in a standardized fashion. 
To characterize our data set, two consultant general 
radiologists with previous experience of ACR-TIRADS 
and thyroid examinations blindly scored all 221 video 
recordings in the study retrospectively. No additional 
information about the patient was made available, except 
that 101 of the 221 nodules had required surgery and that 
some of them were cancers. The radiologists were instructed 
to score the most suspicious nodule in the video file 
according to ACR-TIRADS (6). Only the lobule of interest 
was scored. The average score of the two radiologists was 
used to classify the nodules according to ACR-TIRADS. 
Interobserver reliability was calculated as linearly 
weighted Cohen’s kappa coefficients.
Statistical analysis
All data were organized in Microsoft Excel (Microsoft 
Corporation) and processed in MATLAB R2020b 
(MathWorks). IBM SPSS Statistics (IBM) was used for 
statistical tests.
Ethics approval/consent to participate
The study was approved by the Data Protection Official of 
the University Hospital of North Norway (approval 02050). 
The Norwegian Regional Ethics Committee North waived 
the need for written patient consent (ref 225025).
Results
Of all evaluated nodules (Table 1), about 4 out of 5 
were in women. The age of patients with benign and 
malignant disease was not statistically different (ANOVA 
F(2,218) = 2.29, P = 0.10). Benign operated nodules were 
larger than unoperated presumably benign nodules or 
operated malignant nodules (ANOVA F(2,215) = 18.02, 
P < 0.001, post hoc contrasts t(215) = 5.90, P = <0.001) while 
malignant and unoperated nodules were of equal size 
(t(215) = 0.83, P = 0.41).
We first evaluated the ability of expert US to distinguish 
between benign and malignant thyroid nodules, without 
any TIRADS scoring. Nodules were assigned to predicted 
histopathological entities, and the confidence level was 
scored as described in the Materials and Methods section. 
Of total 101 nodules, 78 US classifications were scored as 
either confident or very confident (Fig. 1A). Twenty-three 
of 101 nodules had lower confidence scores (value 1–3) 
indicating uncertainty, and these nodules were classified 
as 'Uncertain'. To calculate the ability of ultrasound to 
detect malignancy, 'Certain malignant' and 'Uncertain' 
ultrasound evaluation was both considered a positive 
test, as both categories demand further diagnostic or 
therapeutic action. With this definition, ultrasound 
detected cancer with a sensitivity of 97.3% (36/37) and the 
specificity was 78.1% (50/64). The positive predictive value 
was 72.0% while the negative predictive value was 98.0% 
(50/51), yielding an accuracy score of 85.1%. The only 
overlooked cancer in our material (patient ID 94) was a 
4 mm papillary microcarcinoma (mPTC) scored as a colloid 
nodule with a confidence score of 4. It was fine-needle 
biopsied nevertheless and a Bethesda category V scoring 
led to diagnostic hemithyroidectomy and the histological 
diagnosis of mPTC.
As several risk stratification systems for thyroid 
nodules have been published and implemented recently, 
we wanted to compare the performance of expert pattern 
recognition with one of the most commonly used RSS, the 
ACR-TIRADS. Twenty-eight of the 101 nodules were scored 
in TIRADS category 2–3, while the remaining 73 nodules 
were scored TIRADS 4–5 (Fig. 1B). The inter-rater reliability 
was fair (weighted kappa 0.38). The sensitivity for 
malignancy was 97.3%, comparable to expert ultrasound, 
but specificity was only 26.6%. The positive predictive 
value was 43.4%, and the negative predictive value was 
94.4%. Thus, TIRADS categorization successfully ruled in 
cancer patients but had a low ability to rule out cancer.
Recognition-based ultrasound assessment classified 
the later unoperated nodules as mostly benign, clearly 
different from later operated nodules (chi-square 34.1, 
P < 0.0001, Fig. 1A vs 1C), while TIRADS categorization 
for the unoperated nodules did not differ from the 
operated nodules (chi-square 1.88, P = 0.60, Fig. 1B vs 1D).
To evaluate the ability of dedicated US to predict 
histological outcomes in more detail, we compared 
predicted and actual histological outcomes using three 
benign and four malignant categories (Fig. 2). Overall 
accuracy was 71%, and a Cohen’s Kappa was 0.62 
indicating substantial agreement. The precision was good 
for colloid nodules (71%), follicular adenomas (76%), 





Number of nodules 37 64 120
Males (%) 22% 17% 19%
Age (years) 56 ± 3 50 ± 2 58 ± 2
Nodule size (mm) 21 ± 3 38 ± 2 23 ± 2
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papillary thyroid carcinomas (88%), while the other 
categories had too few observations to allow statistical 
assessment. We, therefore, re-categorized our data material 
into fewer categories, corresponding to clinically significant 
entities. Colloid and adenomatoid nodules were merged, 
all follicular neoplasias including follicular cancers were 
merged. Papillary thyroid cancers and anaplastic thyroid 
cancers remained as separate categories. The analysis 
showed that expert ultrasound evaluation could reliably 
differentiate between these four categories (Fig. 3). Overall 
accuracy was 82%, and the Cohen’s Kappa was 0.73 
indicating substantial agreement. The weighted average 
precision was 82%, while the weighted average sensitivity 
Figure 1
Classification of later operated (A and B) and 
unoperated (C and D) thyroid nodules according 
to recognition-based ultrasound (A and C) or 
ACR-TIRADS (B and D). For operated nodules, the 
final histopathology is shown in colors, while for 

















































































































Follicular variant PTC (FV)
Papillary carcinoma (PTC)
Anaplastic carcinoma (ATC)
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Figure 2
Confusion matrix comparing ultrasound prediction with actual 
histopathological diagnosis. Prediction was based on non-invasive 
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Confusion matrix comparing ultrasound prediction with actual 
histopathological diagnosis. Data are the same as in Fig. 2 but grouped 
into the major clinically relevant entities. Overall accuracy was 82%.
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was 83%. The positive predictive value (precision) for each 
sub-category was 80% for colloid/adenomatoid nodules, 
77% for follicular neoplasias, and 88% for papillary thyroid 
carcinomas. All three anaplastic cancers were correctly 
identified. We saw no medullary thyroid cancers in our 
study period.
To assess whether this single operator, recognition-
based method can be replicated, a thyroid ultrasound 
trainee independently scored a subset of 36 nodules 
immediately before or after the expert examined the 
patient. The correlation of raw scoring matrixes was 
relatively high 0.72, and there was substantial agreement 
(weighted kappa value 0.70) on the main diagnosis when 
using the four diagnostic categories of Fig. 3.
Discussion
Our data indicate that thyroid US alone, without cytology, 
can have a high diagnostic value when performed by 
a dedicated operator. The results show the potential 
of expert thyroid US to help avoid invasive FNC and 
reduce the number of diagnostic thyroidectomies. The 
subjectivity of the method is inherent in all ultrasound-
based diagnostic approaches including risk stratification 
systems for thyroid nodules.
The diagnostic performance of ultrasound in this study 
is similar to or better than the published sensitivity and 
specificity of cytological evaluation of thyroid nodules. 
However, a comparison between ultrasound and cytology 
is not reasonable, as the performance of cytology is directly 
dependent on the ultrasound evaluation. Cytological 
sampling is guided by ultrasound and, therefore, strongly 
biased by the quality of the ultrasound examination and 
by the precision of the ultrasound-guided FNC. When 
interpreting the results of this study, we also acknowledge 
that the accuracy of US is user- and equipment-dependent. 
The importance of this should be considered in the clinical 
settings when expert high volume US is not available, and 
the thyroid US and FNC are performed by low volume 
endocrine or ENT surgeons, sometimes not able to properly 
document images and FNC needle positions.
A perceived weakness in our study is the reliance on 
a single ultrasound operator. However, we do not aim 
to describe a systematic methodology for recognition-
based thyroid nodule diagnosis but to demonstrate 
the potential of the ultrasound modality, without 
FNC. Expert recognition depends heavily on human 
pattern recognition and pattern completion processes. 
Such top-down processing normally outperforms feed-
forward algorithms that summarize individual features 
(18). Recognition-based radiological diagnosis can be 
achieved by high volume experts but also using artificial 
intelligence (AI). While many researchers believe that the 
future of thyroid nodule diagnostics is found in molecular 
markers, several papers show that AI performs relatively 
well in detecting thyroid malignancy. Until now, human 
selection of the nodule of interest is still required in 
the AI algorithms (16). We are probably just seeing the 
beginning of AI in medical imaging and expect this field to 
expand considerably.
TIRADS scoring of our data set assigned the vast 
majority of nodules to category 4 and 5, yielding low 
specificity but a high negative predictive value (NPV). The 
tendency to score most nodules in the higher categories 
transmits most of the diagnostic differentiation to 
cytological evaluation, leaving US without significant 
contribution in the clinical decision-making. A 
downstaging of the TIRADS scores would probably not give 
a better selection but could result in low NPV consistent 
with other reports (19). We believe that the role of TIRADS 
is outside thyroid competence centers, where it can be 
very useful for the selection of patients that need referral 
or FNC. However, in dedicated thyroid centers or future 
AI-assisted diagnostics, US evaluation should be more 
ambitious and aspire to predict the pathological entity 
of the thyroid nodules. Expert ultrasound evaluation 
of thyroid nodules reaches beyond TIRADS and ATA 
algorithms, providing an excellent distinction between 
malignant and benign nodules, and high accuracy in 
predicting final histological diagnosis.
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